Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.
about
Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?Locoregional treatment outcomes after multimodality management of inflammatory breast cancer21 years of biologically effective doseMeasurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.Back to the future--radiotherapy in high grade gliomasConcomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up.Exploring two two-edged swords.Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells.Sigma-2 receptors as a biomarker of proliferation in solid tumours.Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery.The first James Kirk memorial lecture. What next in fractionated radiotherapy?Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neckTissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair.NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study.Model-Supported Radiotherapy Personalization: Test of Hyper- and Hypo-Fractionation Effects
P2860
Q30234489-4FA72CAD-20B2-4F1D-8A91-278733466A83Q34150508-FE5063CD-0DFD-45AB-ACF5-830528D356C4Q34584856-64BFB8DB-0DFC-43AE-9F38-CC1D2A5B64DEQ36324701-BA76AA4D-8679-4E4A-8AC0-D6E70BF6C9BEQ36466684-BF407615-5C04-4CFC-B9FC-954A039E208AQ36468064-3E374939-7CC6-482E-81F6-55C70EE23393Q36611240-BDFC31DC-E76C-4A57-988C-78416407DB44Q36611916-6CA8639D-7442-44CE-8A36-F5EA528F4063Q36619918-8EAABBD1-BF2D-4B9B-BB80-EDB5CC96B475Q36621308-1B15729D-6FB5-48F2-806B-4E262ED41011Q36644686-9E179A2D-208E-4813-8928-328373510F01Q40169933-9D8E7948-901B-4877-9493-C938272D16A7Q41788351-0CBD81E1-5F6F-4AEA-905D-E359BB6E52F1Q41961530-5D8626EB-30DC-45CA-8654-8CE41715343BQ42171003-E49B2567-549C-43E0-9F46-A89478C4FA17Q48100633-E74355D9-4105-41E6-BDBD-341418B32AEBQ49629456-F3BA0BA2-38A7-470B-89F4-04B78C3095D2Q58122207-A2DE0598-EB84-4783-A534-D689066F8F13
P2860
Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Accelerated fractionation vs h ...... or several treatments per day.
@en
type
label
Accelerated fractionation vs h ...... or several treatments per day.
@en
prefLabel
Accelerated fractionation vs h ...... or several treatments per day.
@en
P2093
P1476
Accelerated fractionation vs h ...... or several treatments per day.
@en
P2093
Fletcher GH
Thames HD Jr
Withers HR
P304
P407
P577
1983-02-01T00:00:00Z